来自印度的第一批活体捐赠者肝脏再移植:挑战和结果
Shaleen Agarwal1, Rajesh Dey2, Sanjiv Saigal1
1Centre for Liver and Biliary Sciences, Max Superspeciality Hospital, Saket, Delhi, India.
Journal of clinical and experimental hepatology
|February 3, 2025
概括
这项研究报告印度印度.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 移植手术 移植手术
- 胃肠病学 胃肠病学
背景情况:
- 关于活体供体肝移植 (LDLT) 和再移植 (re-LT) 的长期结果,印度数据有限.
- 这项研究介绍了来自印度的第一系列肝脏再移植,详细说明,挑战和结果.
研究的目的:
- 分析肝脏再移植患者的生存结果和术后并发症.
- 为了确定早期与晚期肝脏再移植的指示.
主要方法:
- 对29名肝脏再移植患者的回顾性分析.
- 患者被分为早期 (<30天) 和晚期 (>30天) 重移植组.
- 结果是根据生存率和并发症来评估的.
主要成果:
- 肝脏再移植在29名患者中进行 (0.81%的肝脏移植),主要是在LDLT (93%) 之后进行的.
- 早期的再移植指示包括肝动脉血栓症 (53%) 和移植功能障碍 (47%);晚期的指示是胆道并发症 (50%) 和慢性排斥 (33%).
- 30天死亡率为27%,格兰阴性败血症是主要原因;晚期再移植组的死亡率 (16.6%) 比早期组 (35%) 低.
结论:
- 肝脏再移植,特别是使用活体捐赠者,对于精心挑选的患者来说是一个可行的选择.
- 了解指示和时间对于改善再移植结果至关重要.
相关概念视频
Bone Marrow Sampling and Transplants
277
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
277
Tissue Transplantation
332
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
332


